— Know what they know.
Not Investment Advice

PMHS OTC

Polomar Health Services, Inc.
1W: -29.4% 1M: -60.0% 3M: +1.7% YTD: -85.0%
$0.12
-0.04 (-22.58%)
 
Weekly Expected Move ±29.2%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 36 · $3.4M mcap · 14M float · 0.027% daily turnover · Short 78% of daily vol

Supply Chain Overview

28 relationships
28
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2024-07-02
Earliest Filing
2025-12-12
Latest Filing
partner: 8 customer: 5 licensee: 5 acquirer: 4 target: 3 supplier: 3

Counterparties (Filed by PMHS)

28 relationships

Companies named in PMHS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
ForHumanity Health, Inc. — partner Signatory to the Second Amendment to the Product Fulfillment and Distribution Agreement. 2025-12-12 View
Island 40 Group — partner Signatory to the Second Amendment and designated as PMHS's exclusive B2B/Commercial account management partner. 2025-12-12 View
Polomar Health Services, Inc. PMHS partner Signatory to the Second Amendment and provider of Dry Inhalable products. 2025-12-12 View
Polomar Health Services, Inc. PMHS acquirer Parent company in merger agreement 2025-10-14 View
Polomar Merger Sub, Inc. — acquirer Merger subsidiary in merger agreement 2025-10-14 View
Altanine Inc. — target Target company in merger agreement 2025-10-14 View
Polomar Health Services, Inc. PMHS supplier Parent company of Polomar Specialty Pharmacy, LLC entering into a product fulfillment and distribution agreement. 2025-08-29 View
Polomar Specialty Pharmacy, LLC — supplier Wholly owned subsidiary of Polomar Health Services, Inc. providing product fulfillment and distribution services. 2025-08-29 View
Island 40 Group — partner Tennessee LLC acting as the exclusive commercial account management partner for PMHS. 2025-08-29 View
ForHumanity Health, Inc. — customer Delaware Corporation purchasing products and receiving exclusivity rights for dry inhalable medications. 2025-08-29 View
Polomar Health Services, Inc. PMHS customer Client receiving professional services under the agreement 2025-07-29 View
Profesco, Inc. — supplier Provider of professional services and invoicing entity 2025-07-29 View
Polomar Health Services, Inc. PMHS customer Borrower in a $150,000 promissory note and loan agreement 2025-07-25 View
Polomar Health Services, Inc. PMHS customer Borrower in a loan agreement and securities purchase agreement 2025-07-09 View
Pinata Holdings, Inc. — licensee Licensor of patents and know-how for metformin, sumatriptan, semaglutide, liraglutide, and sildenafil products. 2025-01-14 View
Polomar Health Services, Inc. PMHS licensee Primary licensee and former Trustfeed Corp. organized under Nevada law. 2025-01-14 View
Polomar Specialty Pharmacy, LLC — licensee Wholly-owned subsidiary of Polomar Health Services, Inc. and additional party to the license agreement. 2025-01-14 View
Polomar Specialty Pharmacy, LLC — target Acquired 100% of the company in exchange for common stock 2024-11-12 View
Polomar Acquisition, L.L.C. — partner Party to the Agreement and Plan of Merger and Reorganization 2024-11-12 View
CWR 1, LLC — partner Affiliated with Reprise Management, Inc. 2024-11-12 View
Profesco, Inc. — partner Party to the Professional Services Agreement 2024-11-12 View
Pinata Holdings, Inc. — partner Party to the Know How and Patent License Agreement 2024-11-12 View
Trustfeed Corp. — customer Borrower in a $250,000 promissory note and loan agreement 2024-08-21 View
Pinata Holdings Inc. — licensee Licensor granting know-how and patent licenses for pharmaceutical products 2024-07-05 View
Trustfeed Corp. — licensee Licensee acquiring non-exclusive licenses to manufacture and distribute products 2024-07-05 View
Trustfeed Corp. — acquirer Parent company acquiring Polomar Specialty Pharmacy, LLC in a merger and reorganization. 2024-07-02 View
Polomar Acquisition, L.L.C. — acquirer Merger subsidiary of Trustfeed Corp. used to acquire Polomar Specialty Pharmacy, LLC. 2024-07-02 View
Polomar Specialty Pharmacy, LLC — target Target company being merged into Polomar Acquisition, L.L.C. and becoming a wholly-owned subsidiary of Trustfeed Corp. 2024-07-02 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-07-30 Officer/Director Change; Bylaws Amendment; Exhibits View
2026-07-20 Officer/Director Change; Exhibits View
2026-07-17 Accountant Change; Exhibits View
2026-07-06 Officer/Director Change; Bylaws Amendment; Exhibits View
2026-06-15 Termination of Agreement; Exhibits View
2026-05-15 Material Agreement; Other Events; Exhibits Agreement View
2026-04-29 Termination of Agreement; Exhibits View
2025-12-12 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-10-14 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-08-29 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-29 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-25 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-24 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-09 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of Agreement View
2025-04-16 Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh View
2025-03-17 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-03-05 Non-Reliance on Previously Issued Financial Statements; Financial Statements and Exhibits View
2025-01-14 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2024-11-12 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2024-10-25 Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits Acquisition View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms